Consultations

You are here

Avis de Prospection- pèlerinage Hadj 2024

by communication / 17 Mar, 2024

Avis de consultation 25-MED-2024 TROPICAMIDE COLLY 0.5%

by communication / 17 Mar, 2024

Avis de consultation 26-MED-2024 GENTAMICINE COLLY 3MG.ML (0.3%)

by communication / 17 Mar, 2024

Avis de consultation 27-MED-2024 NEOMYCINE COLLY 0.35%

by communication / 17 Mar, 2024

AVIS DE CONSULTATION N°24-MED-2024 - ACIDE FUSIDIQUE SEL DE SODIUM PDE DERM 2G%

by communication / 13 Mar, 2024

AVIS DE CONSULTATION N°23-MED-2024 - ACICLOVIR INJ 250 MG

by communication / 13 Mar, 2024

AVIS DE PROROGATION CONSULTATION N°19-MED-2024 - N-ACETYLCYSTEINE INJ 5G-25ML

by communication / 13 Mar, 2024

AVIS D'ATTRIBUTION PROVISOIRE CONSULTATION N°05-MED2024 - ACIDE TRANEXAMIQUE INJ 500MG-5ML

by communication / 12 Mar, 2024

AVIS DE PROROGATION - CONSULTATION N°17-MED-2024 - LAMIVUDINE 150MG COMP

by communication / 12 Mar, 2024

AVIS DE PROROGATION - CONSULTATION N°18-MED-2024 - NEVIRAPINE SUSP BUV 50MG-5ML

by communication / 12 Mar, 2024

Pages

09789332719.png